癌症中的衰老巨细胞:瘤进展中的作用和治疗机会
相关实验视频
Updated: May 9, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Tianzi Wang1, Chang Liu1,2, Xuefeng Hu1,2
1Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
衰老的巨细胞,一种免疫细胞,显著推动癌症的进展. 用诸如老化药物等疗法准这些细胞为有效的癌症治疗提供了有希望的新途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 衰老的巨细胞是瘤微环境中的关键参与者.
- 这些细胞表现出功能性改变,促进瘤进展.
研究的目的:
- 审查巨细胞衰老在癌症中的多方面的作用.
- 分析将衰老的巨细胞与瘤进展联系起来的分子机制.
- 探索针对老化的巨细胞的新型治疗策略.
主要方法:
- 对参与巨衰老的分子机制和途径的全面分析.
- 系统检查老化的巨细胞中各种变化的系统检查.
- 整合当前的分子研究和治疗进步.
主要成果:
- 衰老的巨细胞通过复杂的改变显著促进瘤的进展.
- 从多个角度建立了衰老的巨细胞和瘤进展之间的联系.
- 确定了老化剂,衰老调节剂和免疫疗法作为潜在的治疗方法.
结论:
- 衰老的巨体在癌症治疗中是一个重要的治疗点.
- 准衰老的巨细胞为癌症治疗提供了新的机会.
- 本综述为临床应用提供了理论基础和实际见解.
更多相关视频
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Mesenchymal Stem Cells